mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
4e-07 |
mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
9e-06 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
6e-05 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
9e-05 |
mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0001 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.0003 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.0004 |
mRNA |
PD-0325901 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.0005 |
mRNA |
pluripotin |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0007 |